Home › Stargardt Disease › Pennsylvania › Pittsburgh
Stargardt Disease clinical trials in Pittsburgh, PA
3 studies for Stargardt Disease are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of ALK-001 on the Progression of Stargardt Disease
RecruitingPhase 3
- UPMC Vision Institute, Pittsburgh
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
RecruitingObservational study
- University of Pittsburgh Medical Center, Pittsburgh
Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
RecruitingPhase 1/2
- UPMC Vision Institute, Pittsburgh
Stargardt Disease trials in other cities
- Dallas, TX9 studies
- Boston, MA5 studies
- Phoenix, AZ4 studies
- Houston, TX4 studies
- Miami, FL4 studies
- Portland, OR4 studies
- Gainesville, FL4 studies
- Cincinnati, OH4 studies
- Ann Arbor, MI4 studies
- Aurora, CO3 studies
- Baltimore, MD3 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)42 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Melanoma31 studies
- Metastatic Cancer31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer24 studies
- Lung Cancer23 studies
- Prostate Cancer23 studies
- Stroke22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.